PP

Prudvi Panjala

Active Director Director DIN 09091918
DIN 09091918 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Prudvi Panjala

Data last updated:

Prudvi Panjala is a Director at Aariv Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Aariv Pharmaceuticals Private Limited reported revenue of ₹14.7 Lakh (FY 2022).

DIN 09091918
Primary Designation Director
Industry Chemicals
First Appointment 04 Mar 2021
Oldest Company Age 5 yrs
Largest company Aariv Pharmaceuticals Private Limited · ₹14.7 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Mar 20212021₹14.7 Lakh (FY 2022)Active

Board colleagues of Prudvi Panjala

NameDINCompanyDesignation
Jagadeeshwar Vangapelly09091919Aariv Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aariv Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prudvi Panjala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prudvi Panjala

Prudvi Panjala currently holds 1 directorship: Aariv Pharmaceuticals Private Limited (Director, since 04 Mar 2021, revenue ₹14.7 Lakh (FY 2022)).

Prudvi Panjala was first appointed on 04 Mar 2021 as Director at Aariv Pharmaceuticals Private Limited.

The current boards of Prudvi Panjala's companies include Jagadeeshwar Vangapelly (Aariv Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available